Literature DB >> 16103547

Cardiac magnetic resonance imaging: long term reproducibility of the late enhancement signal in patients with chronic coronary artery disease.

H Bülow1, C Klein, I Kuehn, R Hollweck, S G Nekolla, K Schreiber, F Haas, J Böhm, B Schnackenburg, R Lange, M Schwaiger.   

Abstract

OBJECTIVE: To determine long term reproducibility of the late enhancement (LE) signal in contrast enhanced magnetic resonance imaging (MRI) and potential changes of the signal after revascularisation.
METHODS: 33 patients (29 men, mean (SD) 61 (11) years) with coronary artery disease (CAD) and left ventricular dysfunction (ejection fraction 30 (7)%) underwent two contrast enhanced MRI procedures within 9 (3) months. Fifteen patients (group A: 14 men, 59 (12) years) had no interventions between the two studies. Eighteen patients underwent revascularisation after MRI 1 (group B: 15 men, 62 (9) years). Changes in the LE signal between the first and second MRIs were investigated in both groups as well as intraobserver and interobserver variabilities for delineation of the signal.
RESULTS: The LE signal was highly reproducible in groups A and B for segmental analysis (concordance 86% v 82%, respectively; kappa = 0.70 v 0.67) and summed scores (group A: r = 0.97, p < 0.001; group B: r = 0.93, p < 0.001). The LE signal was quantified as 27 (27) cm3 in group A versus 30 (16) cm3 in group B in the first MRI and 26 (25) cm3 versus 30 (15) cm3, respectively, for the second MRI (both not significant). Moreover, low intraobserver and interobserver variabilities were observed in segmental analysis (kappa = 0.86 and 0.74, respectively, for group A, and kappa = 0.87 and 0.82, respectively, for group B).
CONCLUSION: In patients with chronic CAD, the LE signal in contrast enhanced MRI is very stable over an extended time period. These results further characterise contrast enhanced MRI as a useful tool for myocardial viability assessment. Low intraobserver and interobserver variabilities promise robustness of the method for clinical application.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103547      PMCID: PMC1769072          DOI: 10.1136/hrt.2004.045609

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  27 in total

1.  Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging.

Authors:  H B Hillenbrand; R J Kim; M A Parker; D S Fieno; R M Judd
Journal:  Circulation       Date:  2000-10-03       Impact factor: 29.690

2.  The changing anatomic reference base of evolving myocardial infarction. Underestimation of myocardial collateral blood flow and overestimation of experimental anatomic infarct size due to tissue edema, hemorrhage and acute inflammation.

Authors:  K A Reimer; R B Jennings
Journal:  Circulation       Date:  1979-10       Impact factor: 29.690

3.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

4.  Minor cardiac troponin T release in patients undergoing coronary artery bypass graft surgery on a beating heart.

Authors:  T Shiga; K Terajima; J Matsumura; A Sakamoto; R Ogawa
Journal:  J Cardiothorac Vasc Anesth       Date:  2000-04       Impact factor: 2.628

5.  Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction.

Authors:  R J Kim; E L Chen; J A Lima; R M Judd
Journal:  Circulation       Date:  1996-12-15       Impact factor: 29.690

6.  Contrast-enhanced MRI for the assessment of myocardial viability after permanent coronary artery occlusion.

Authors:  R S Pereira; F S Prato; K S Lekx; J Sykes; G Wisenberg
Journal:  Magn Reson Med       Date:  2000-08       Impact factor: 4.668

7.  Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms.

Authors:  J A Lima; R M Judd; A Bazille; S P Schulman; E Atalar; E A Zerhouni
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

8.  Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: a randomized trial using cardiovascular magnetic resonance imaging and biochemical markers.

Authors:  Joseph B Selvanayagam; Steffen E Petersen; Jane M Francis; Matthew D Robson; Attila Kardos; Stefan Neubauer; David P Taggart
Journal:  Circulation       Date:  2004-01-19       Impact factor: 29.690

9.  Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction.

Authors:  K Ramani; R M Judd; T A Holly; T B Parrish; V H Rigolin; M A Parker; C Callahan; S W Fitzgerald; R O Bonow; F J Klocke
Journal:  Circulation       Date:  1998-12-15       Impact factor: 29.690

10.  Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts.

Authors:  R M Judd; C H Lugo-Olivieri; M Arai; T Kondo; P Croisille; J A Lima; V Mohan; L C Becker; E A Zerhouni
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

View more
  7 in total

1.  Quantitative myocardial distribution volume from dynamic contrast-enhanced MRI.

Authors:  Nathan A Pack; Edward V R Dibella; Brent D Wilson; Christopher J McGann
Journal:  Magn Reson Imaging       Date:  2008-02-20       Impact factor: 2.546

2.  Prognostic value of combined magnetic resonance myocardial perfusion imaging and late gadolinium enhancement.

Authors:  Rungroj Krittayaphong; Vithaya Chaithiraphan; Adisak Maneesai; Suthipol Udompanturak
Journal:  Int J Cardiovasc Imaging       Date:  2011-04-10       Impact factor: 2.357

Review 3.  Contrast-enhanced magnetic resonance imaging in the assessment of myocardial infarction and viability.

Authors:  Antti Saraste; Stephan Nekolla; Markus Schwaiger
Journal:  J Nucl Cardiol       Date:  2007-12-21       Impact factor: 5.952

4.  Magnetic resonance imaging in the diagnostics of myocardial infarction.

Authors:  Anna Kociemba; Katarzyna Karmelita-Katulska; Andrzej Siniawski; Magdalena Lanocha; Magdalena Janus; Marek Stajgis; Stefan Grajek; Małgorzata Pyda
Journal:  Pol J Radiol       Date:  2011-07

5.  Differential MR delayed enhancement patterns of chronic myocardial infarction between extracellular and intravascular contrast media.

Authors:  Jian Wang; Bo Xiang; Hung Yu Lin; Hongyu Liu; Darren Freed; Rakesh C Arora; Ganghong Tian
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

6.  The association of cardiac function, structure, and glycemic control in patients with old myocardial infarction: a study using cardiac magnetic resonance.

Authors:  Junko Hamai; Akinobu Nakamura; Shingo Kato; Yasuo Terauchi
Journal:  Diabetol Int       Date:  2016-05-06

7.  Pathological mechanism for delayed hyperenhancement of chronic scarred myocardium in contrast agent enhanced magnetic resonance imaging.

Authors:  Jian Wang; Bo Xiang; Hung-Yu Lin; Hongyu Liu; Darren Freed; Rakesh C Arora; Ganghong Tian
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.